Operations

A calculated numeric value representing the overall quality, safety, or appropriateness of a medication substitution event. Used in PBM analytics and formulary management reporting to rank or compare alternative drug selections against clinical guidelines and therapeutic equivalence standards.

An ordinal number indicating the position of a medication substitution event within a series of dispensing or formulary change transactions. Used in pharmacy claims processing and clinical data systems to maintain the correct chronological order of multiple substitution events for a single prescription.

A classification indicating the clinical seriousness of a medication substitution, ranging from routine generic interchange to high-risk therapeutic substitutions requiring clinical oversight. Used in pharmacy safety monitoring and formulary management to prioritize review of substitutions with elevated patient risk.

The biological sex of the patient associated with a medication substitution event, used to validate clinical appropriateness of the alternative drug. Captured in pharmacy and clinical records to support sex-specific dosing rules, contraindication checks, and formulary substitution eligibility criteria.

The originating system, formulary rule, prescriber directive, or dispensing channel that initiated a medication substitution event. Used in pharmacy claims and PBM audit reporting to identify whether a substitution was driven by formulary policy, drug shortage, insurer mandate, or pharmacist clinical judgment.

The calendar date on which dispensing of an alternative medication began in place of the originally prescribed drug. Used in pharmacy claims and medication management systems to establish the effective period of a substitution and support adherence tracking and formulary compliance reporting.

The specific time at which administration or dispensing of an alternative medication commenced in place of the originally prescribed drug. Used in inpatient pharmacy and clinical documentation systems to record the precise onset of a substitution for medication reconciliation and patient safety audits.

The US state or Canadian province associated with a drug substitution event in pharmacy dispensing records. Used to track the geographic jurisdiction where a generic or therapeutic equivalent was dispensed in place of the originally prescribed medication.

Indicates whether a drug substitution was permitted, performed, or denied at the point of dispensing. In pharmacy claims, this reflects pharmacist or plan decisions such as generic substitution allowed, brand medically necessary, or therapeutic interchange applied per formulary policy.

The physical street address of the pharmacy or dispensing location where a drug substitution was processed. Used in pharmacy claims and dispensing records to identify the site where a generic or therapeutic equivalent was dispensed in place of the prescribed drug.

The drug concentration or dosage strength of the substituted medication dispensed in place of the originally prescribed drug. Expressed in units such as mg or mcg, this field confirms the substituted product matches the therapeutic equivalence required by the prescriber or formulary.

A partial cost or quantity sum associated with a drug substitution transaction before final adjustments, copays, or plan contributions are applied. Used in pharmacy benefit management and claims adjudication to calculate cost-sharing components for substituted medications.

The intended replacement drug or therapeutic equivalent that a substitution rule or formulary policy designates as the preferred alternative to the originally prescribed medication. Used in pharmacy benefit management to guide dispensing decisions and formulary substitution protocols.

A classification code identifying the drug category or therapeutic class under which a substituted medication is grouped. Used in pharmacy benefit management and formulary systems to apply substitution rules, tier placement, and coverage policies to equivalent drug classes.

The storage temperature requirement for the substituted drug dispensed in place of the originally prescribed medication. Critical in pharmacy dispensing for specialty and biologic medications where cold chain compliance must be verified to ensure therapeutic equivalence and drug stability.

The date on which a drug substitution authorization, formulary override, or therapeutic interchange agreement expires or is discontinued. Used in pharmacy benefit management to enforce time-limited substitution approvals and trigger formulary compliance reviews at the plan level.

The specific time of day at which a drug substitution was processed or dispensed at the pharmacy. Used in pharmacy dispensing records and audit logs to establish the precise moment a generic or therapeutic equivalent was substituted for the originally prescribed medication.

The combined date and time value recording when a drug substitution event was processed, adjudicated, or documented in the pharmacy or claims system. Used for audit trails, real-time benefit processing, and longitudinal tracking of substitution activity across dispensing events.

The formal name or label assigned to a drug substitution rule, formulary policy, or therapeutic interchange protocol. Used in pharmacy benefit management systems to identify and reference specific substitution programs applied during claims adjudication or medication dispensing workflows.

The aggregate cost or quantity representing the full value of a drug substitution transaction after all adjustments, plan contributions, and member cost-sharing are applied. Used in pharmacy claims reporting to summarize the financial impact of dispensing a substituted medication.